Clinical Trial Update: Study of Palbociclib in MLL-rearranged Acute Leukemias [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating palbociclib in MLL-rearranged acute leukemias (AML and ALL) across Phase 1 and Phase 2 ongoing with currently unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: UNKNOWN